Results Healthcare is delighted to have been the exclusive financial advisor to 2e Group, a full-service healthcare creative agency focused on drug launches and brand acceleration, in its strategic partnership with Fishawack Group, an independent healthcare communications agency. This transaction reinforces our cross-border and cross-sector expertise advising best in class businesses in achieving their international growth objectives.
Since relaunching as a healthcare focused agency in 2014, 2e rapidly developed into one of the leading healthcare creative agencies in the United States and was named Healthcare Agency of the Year three years in a row by MM&M. Offering a capabilities suite that includes advisory, consulting, marketing, communications, experiential, and training services, 2e has become a prominent player uniquely positioned to take advantage of an evolving audience and an increase in digital technology in the $140 billion pharmaceutical marketing industry. With a capabilities spectrum focused on providing business intelligence, empowering with technology, and building brands as well as teams, 2e saw years of growing momentum with a client track record in North America, Europe, and Asia.
With 2e’s strong growth since relaunching, the company’s competitive advantage, and the pharmaceutical market at an inflection point, the opportunity presented itself for 2e to seek a partner to diversify its therapeutic area capabilities and increase its number of mid-sized drug launches. With Fishawack’s goal to increase its US presence, 2e was perfectly situated to take advantage of the growing interest in its capabilities.
Results Healthcare was chosen as the financial advisor to help 2e with its strategic growth initiatives given Results Healthcare’s experience in similar healthcare communications transactions and understanding of the capabilities strategic and financial partners are targeting.
Following a comprehensive sweep of potential strategic partners from a multitude of verticals including healthcare communications, health tech, CROs, technology, consulting, and PE, Results Healthcare identified a select number of suitable parties, and following the submission of several compelling bids, assisted 2e in its decision to go with Fishawack because of the latter’s commitment to increasing the services it offered commercial and medical affairs teams.
Ross Toohey, CEO, 2e
We could not have achieved our expansion goals without Results Healthcare. Their expertise, relationships and intelligence helped position 2e for optimal value as we explored strategic options. They have been a critical part of our advisory team, and will continue to be key strategic partners for our business for years to come. The future of our business has been strengthened and secured thanks to Results Healthcare.